Constitutive levels of cAMP-dependent protein kinase activity determine sensitivity of human multidrug-resistant leukaemic cell lines to growth inhibition and apoptosis by forskolin and tumour necrosis factor alpha.

The cyclic adenosine monophosphate (cAMP)-dependent protein kinase (PKA) signal pathway regulates cell proliferation, differentiation and cell death. It may also regulate the multidrug resistance (MDR) phenotype in leukaemic cells. These data showed that MDR1+ K/Dau600 cells exhibited a higher basal level of PKA activity than MDR− parental cells. The significance of this on tumour necrosis factor α (TNFα)-induced apoptosis and cytostasis was investigated further. In comparison with MDR1− parental cells, K/Dau600 cells had a higher expression of PKA regulatory subunit RIα and nuclear catalytic subunit PKAcα. They were also more susceptible to inhibition of proliferation and induction of apoptosis by TNFα and/or forskolin, but this could be attenuated by H89. An increase in cAMP was associated with the apoptosis in the K/Dau600 cell line. Forskolin inactivated NF-κB in K/Dau600 cells but not in K562 cl.6 cells, whereas TNF activated NF-κB in K562 cl.6 cells but not in K/Dau600 cells. 8-Cl-cAMP exhibited similar inhibitory effects on the proliferation of all of the cell lines used via its metabolite 8-Cl-adenosine, which indicates that these effects were independent of residual PKA or cAMP. Therefore, the differential sensitivity to apoptosis and/or growth inhibition could be mediated via cAMP, partly through PKA via NF-κB and partly by PKA-independent pathways.